(Q36563885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

Role of vascular endothelial growth factor in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

2

Michaël Peyromaure

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

Nicolas Barry Delongchamps

28 December 2019

series ordinal

1

object named as

Nicolas Barry Delongchamps

1 reference

28 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

language of work or name

English

0 references

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

244-248

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

The biology of VEGF and its receptors

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Cellular response to androgen depletion and repletion in the rat ventral prostate: autoradiography and morphometric analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Androgen receptor localization in different cell types of the adult rat prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Expression of vascular endothelial growth factor receptors in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Serum levels of vascular endothelial growth factor in patients undergoing prostate biopsy for suspicion of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Endocavitary (laparoscopic) pelvic lymphadenectomy with specific indications in urologic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.03.010

10.1016/J.UROLOGY.2006.03.010

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16904427%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference